| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5902378 | Journal of Diabetes and its Complications | 2015 | 6 Pages |
Abstract
In this small study, short-term treatment with naltrexone did not improve recognition of hypoglycemia symptoms or counterregulatory hormone response during experimental hypoglycemia in subjects with T1D and IAH. Whether this lack of effect is related to the small sample size or due to the dose, the advanced stage of study population or the drug itself should be the subject of future investigation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Amir Moheet, Silvia Mangia, Anjali Kumar, Nolawit Tesfaye, Lynn E. Eberly, Yun Bai, Kristine Kubisiak, Elizabeth R. Seaquist,